BIAF·09076W307·US·equity·Healthcare - Diagnostics & Research-13D/G
BIAF (BIOAFFINITY TECHNOLOGIES INC) is held by 7 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($184,961), Schonfeld Strategic Advisors LLC ($93,500), STATE STREET CORP ($55,098). Net institutional sentiment: Mixed.
See how BIAF's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer